10-Q Filing

NEOGENOMICS INC CIK: 1077183 Q2 2017

Filing Information

Form Type	10-Q
Accession Number	`0001564590-17-015930`
Period End Date	20170630
Filing Date	20170807
Fiscal Year	2017
Fiscal Period	Q2
XBRL Instance	neo-20170630.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 80 Income Statement 84 Cash Flow Statement 65

Balance Sheet 80 line items

Line Item	Tag	Value	Unit	Period
Accounts receivable, allowance for doubtful accounts	`AllowanceForDoubtfulAccountsReceivable`	$11.63M	USD	Point-in-time
Accounts receivable, allowance for doubtful accounts	`AllowanceForDoubtfulAccountsReceivable`	$13.70M	USD	Point-in-time
Property and equipment, accumulated depreciation	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$34.60M	USD	Point-in-time
Property and equipment, accumulated depreciation	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$27.10M	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$23.42M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$12.53M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$10.93M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$21.79M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	250.00M	shares	Point-in-time
Accounts receivable (net of allowance for doubtful accounts of $11,629 and $13,699, respectively)	`AccountsReceivableNetCurrent`	$55.51M	USD	Point-in-time
Accounts receivable (net of allowance for doubtful accounts of $11,629 and $13,699, respectively)	`AccountsReceivableNetCurrent`	$61.75M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	250.00M	shares	Point-in-time
Inventories	`InventoryNet`	$6.25M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	79.34M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	78.57M	shares	Point-in-time
Inventories	`InventoryNet`	$5.46M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	78.57M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	79.34M	shares	Point-in-time
Other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$5.22M	USD	Point-in-time
Other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$4.54M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$78.83M	USD	Point-in-time
Redeemable Convertible Preferred Stock, par value	`TemporaryEquityParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Redeemable Convertible Preferred Stock, par value	`TemporaryEquityParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Total current assets	`AssetsCurrent`	$83.36M	USD	Point-in-time
Property and equipment (net of accumulated depreciation of $34,604 and $27,102, respectively)	`PropertyPlantAndEquipmentNet`	$34.04M	USD	Point-in-time
Property and equipment (net of accumulated depreciation of $34,604 and $27,102, respectively)	`PropertyPlantAndEquipmentNet`	$35.59M	USD	Point-in-time
Redeemable Convertible Preferred Stock, shares authorized	`TemporaryEquitySharesAuthorized`	50.00M	shares	Point-in-time
Redeemable Convertible Preferred Stock, shares authorized	`TemporaryEquitySharesAuthorized`	50.00M	shares	Point-in-time
Intangible assets, net	`FiniteLivedIntangibleAssetsNet`	$73.61M	USD	Point-in-time
Intangible assets, net	`FiniteLivedIntangibleAssetsNet`	$77.06M	USD	Point-in-time
Redeemable Convertible Preferred Stock, shares issued	`TemporaryEquitySharesIssued`	6.60M	shares	Point-in-time
Redeemable Convertible Preferred Stock, shares issued	`TemporaryEquitySharesIssued`	6.60M	shares	Point-in-time
Goodwill	`Goodwill`	$147.02M	USD	Point-in-time
Redeemable Convertible Preferred Stock, shares outstanding	`TemporaryEquitySharesOutstanding`	6.60M	shares	Point-in-time
Goodwill	`Goodwill`	$147.02M	USD	Point-in-time
Redeemable Convertible Preferred Stock, shares outstanding	`TemporaryEquitySharesOutstanding`	6.60M	shares	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$302.00K	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$174.00K	USD	Point-in-time
Total assets	`Assets`	$337.12M	USD	Point-in-time
Total assets	`Assets`	$339.88M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$16.78M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$15.59M	USD	Point-in-time
Accrued compensation	`EmployeeRelatedLiabilitiesCurrent`	$8.35M	USD	Point-in-time
Accrued compensation	`EmployeeRelatedLiabilitiesCurrent`	$7.78M	USD	Point-in-time
Accrued expenses and other liabilities	`AccruedLiabilitiesAndOtherLiabilities`	$4.25M	USD	Point-in-time
Accrued expenses and other liabilities	`AccruedLiabilitiesAndOtherLiabilities`	$3.19M	USD	Point-in-time
Short-term portion of capital leases	`CapitalLeaseObligationsCurrent`	$4.89M	USD	Point-in-time
Short-term portion of capital leases	`CapitalLeaseObligationsCurrent`	$4.81M	USD	Point-in-time
Short-term portion of loans	`SecuredDebtCurrent`	$3.83M	USD	Point-in-time
Short-term portion of loans	`SecuredDebtCurrent`	$3.84M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$35.20M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$38.11M	USD	Point-in-time
Long-term portion of capital leases	`CapitalLeaseObligationsNoncurrent`	$5.38M	USD	Point-in-time
Long-term portion of capital leases	`CapitalLeaseObligationsNoncurrent`	$5.31M	USD	Point-in-time
Long-term portion of loans, net	`SecuredLongTermDebt`	$68.45M	USD	Point-in-time
Long-term portion of loans, net	`SecuredLongTermDebt`	$70.26M	USD	Point-in-time
Revolving credit facility, net	`LongTermLineOfCredit`	$21.80M	USD	Point-in-time
Revolving credit facility, net	`LongTermLineOfCredit`	$26.91M	USD	Point-in-time
Deferred income tax liability, net	`DeferredTaxLiabilities`	$7.43M	USD	Point-in-time
Deferred income tax liability, net	`DeferredTaxLiabilities`	$14.97M	USD	Point-in-time
Total long-term liabilities	`LiabilitiesNoncurrent`	$108.10M	USD	Point-in-time
Total long-term liabilities	`LiabilitiesNoncurrent`	$112.41M	USD	Point-in-time
Total liabilities	`Liabilities`	$143.31M	USD	Point-in-time
Total liabilities	`Liabilities`	$150.52M	USD	Point-in-time
Commitments and contingencies - see Note I	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies - see Note I	`CommitmentsAndContingencies`	-	USD	Point-in-time
Series A Redeemable Convertible Preferred Stock, $0.001 par value, (50,000,000 shares authorized; 6,600,000 shares issued and outstanding)	`RedeemableNoncontrollingInterestEquityPreferredCarryingAmount`	$22.87M	USD	Point-in-time
Series A Redeemable Convertible Preferred Stock, $0.001 par value, (50,000,000 shares authorized; 6,600,000 shares issued and outstanding)	`RedeemableNoncontrollingInterestEquityPreferredCarryingAmount`	$27.68M	USD	Point-in-time
Common stock, $0.001 par value, (250,000,000 shares authorized; 79,340,374 and 78,571,158 shares issued and outstanding, respectively)	`CommonStockValueOutstanding`	$79.00K	USD	Point-in-time
Common stock, $0.001 par value, (250,000,000 shares authorized; 79,340,374 and 78,571,158 shares issued and outstanding, respectively)	`CommonStockValueOutstanding`	$79.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$216.10M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$220.62M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-51.80M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-52.46M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$168.90M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$163.72M	USD	Point-in-time
Total liabilities, redeemable convertible preferred stock and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$337.12M	USD	Point-in-time
Total liabilities, redeemable convertible preferred stock and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$339.88M	USD	Point-in-time

Income Statement 84 line items

Line Item	Tag	Value	Unit	Period
Clinical testing	`ClinicalTestingRevenue`	$56.32M	USD	1 Quarter
Clinical testing	`ClinicalTestingRevenue`	$116.48M	USD	2 Qtrs
Clinical testing	`ClinicalTestingRevenue`	$59.79M	USD	1 Quarter
Clinical testing	`ClinicalTestingRevenue`	$110.94M	USD	2 Qtrs
Pharma Services	`PharmaServices`	$11.90M	USD	2 Qtrs
Pharma Services	`PharmaServices`	$11.29M	USD	2 Qtrs
Pharma Services	`PharmaServices`	$6.30M	USD	1 Quarter
Pharma Services	`PharmaServices`	$6.81M	USD	1 Quarter
Total Revenue	`SalesRevenueServicesNet`	$127.77M	USD	2 Qtrs
Total Revenue	`SalesRevenueServicesNet`	$63.13M	USD	1 Quarter
Total Revenue	`SalesRevenueServicesNet`	$66.09M	USD	1 Quarter
Total Revenue	`SalesRevenueServicesNet`	$122.83M	USD	2 Qtrs
COST OF REVENUE	`CostOfServices`	$34.52M	USD	1 Quarter
COST OF REVENUE	`CostOfServices`	$69.39M	USD	2 Qtrs
COST OF REVENUE	`CostOfServices`	$34.91M	USD	1 Quarter
COST OF REVENUE	`CostOfServices`	$67.06M	USD	2 Qtrs
GROSS PROFIT	`GrossProfit`	$31.18M	USD	1 Quarter
GROSS PROFIT	`GrossProfit`	$55.78M	USD	2 Qtrs
GROSS PROFIT	`GrossProfit`	$28.61M	USD	1 Quarter
GROSS PROFIT	`GrossProfit`	$58.37M	USD	2 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$18.78M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$36.78M	USD	2 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$43.48M	USD	2 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$22.68M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$947.00K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$1.31M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$2.75M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$1.81M	USD	2 Qtrs
Sales and marketing	`SellingAndMarketingExpense`	$6.33M	USD	1 Quarter
Sales and marketing	`SellingAndMarketingExpense`	$6.24M	USD	1 Quarter
Sales and marketing	`SellingAndMarketingExpense`	$12.13M	USD	2 Qtrs
Sales and marketing	`SellingAndMarketingExpense`	$11.89M	USD	2 Qtrs
Total operating expenses	`OperatingExpenses`	$26.41M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$57.17M	USD	2 Qtrs
Total operating expenses	`OperatingExpenses`	$51.66M	USD	2 Qtrs
Total operating expenses	`OperatingExpenses`	$29.86M	USD	1 Quarter
INCOME FROM OPERATIONS	`OperatingIncomeLoss`	$2.19M	USD	1 Quarter
INCOME FROM OPERATIONS	`OperatingIncomeLoss`	$1.20M	USD	2 Qtrs
INCOME FROM OPERATIONS	`OperatingIncomeLoss`	$1.31M	USD	1 Quarter
INCOME FROM OPERATIONS	`OperatingIncomeLoss`	$4.11M	USD	2 Qtrs
Interest expense, net	`InterestIncomeExpenseNet`	$-2.77M	USD	2 Qtrs
Interest expense, net	`InterestIncomeExpenseNet`	$-3.04M	USD	2 Qtrs
Interest expense, net	`InterestIncomeExpenseNet`	$-1.41M	USD	1 Quarter
Interest expense, net	`InterestIncomeExpenseNet`	$-1.45M	USD	1 Quarter
Income (loss) before taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$1.07M	USD	2 Qtrs
Income (loss) before taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-1.58M	USD	2 Qtrs
Income (loss) before taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-97.00K	USD	1 Quarter
Income (loss) before taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$745.00K	USD	1 Quarter
Income tax (benefit) expense	`IncomeTaxExpenseBenefit`	$-879.00K	USD	2 Qtrs
Income tax (benefit) expense	`IncomeTaxExpenseBenefit`	$505.00K	USD	2 Qtrs
Income tax (benefit) expense	`IncomeTaxExpenseBenefit`	$-54.00K	USD	1 Quarter
Income tax (benefit) expense	`IncomeTaxExpenseBenefit`	$332.00K	USD	1 Quarter
NET INCOME (LOSS)	`NetIncomeLoss`	$568.00K	USD	2 Qtrs
NET INCOME (LOSS)	`NetIncomeLoss`	$-43.00K	USD	1 Quarter
NET INCOME (LOSS)	`NetIncomeLoss`	$413.00K	USD	1 Quarter
NET INCOME (LOSS)	`NetIncomeLoss`	$-697.00K	USD	2 Qtrs
Deemed dividends on preferred stock	`RedeemablePreferredStockDividends`	$929.00K	USD	1 Quarter
Deemed dividends on preferred stock	`RedeemablePreferredStockDividends`	$1.84M	USD	1 Quarter
Deemed dividends on preferred stock	`RedeemablePreferredStockDividends`	$3.68M	USD	2 Qtrs
Deemed dividends on preferred stock	`RedeemablePreferredStockDividends`	$1.82M	USD	2 Qtrs
Amortization of preferred stock beneficial conversion feature	`AmortizationOfPreferredStockBeneficialConversionFeature`	$1.71M	USD	1 Quarter
Amortization of preferred stock beneficial conversion feature	`AmortizationOfPreferredStockBeneficialConversionFeature`	$3.38M	USD	2 Qtrs
Amortization of preferred stock beneficial conversion feature	`AmortizationOfPreferredStockBeneficialConversionFeature`	$3.73M	USD	1 Quarter
Amortization of preferred stock beneficial conversion feature	`AmortizationOfPreferredStockBeneficialConversionFeature`	$7.45M	USD	2 Qtrs
NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-5.90M	USD	2 Qtrs
NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-2.68M	USD	1 Quarter
NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-10.56M	USD	2 Qtrs
NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-5.15M	USD	1 Quarter
Basic	`IncomeLossFromContinuingOperationsPerBasicShare`	$-0.07	USD	1 Quarter
Basic	`IncomeLossFromContinuingOperationsPerBasicShare`	$-0.14	USD	2 Qtrs
Basic	`IncomeLossFromContinuingOperationsPerBasicShare`	$-0.03	USD	1 Quarter
Basic	`IncomeLossFromContinuingOperationsPerBasicShare`	$-0.07	USD	2 Qtrs
Diluted	`IncomeLossFromContinuingOperationsPerDilutedShare`	$-0.14	USD	2 Qtrs
Diluted	`IncomeLossFromContinuingOperationsPerDilutedShare`	$-0.03	USD	1 Quarter
Diluted	`IncomeLossFromContinuingOperationsPerDilutedShare`	$-0.07	USD	1 Quarter
Diluted	`IncomeLossFromContinuingOperationsPerDilutedShare`	$-0.07	USD	2 Qtrs
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	79.41M	shares	1 Quarter
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	77.45M	shares	1 Quarter
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	76.76M	shares	2 Qtrs
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	79.08M	shares	2 Qtrs
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	79.41M	shares	1 Quarter
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	77.45M	shares	1 Quarter
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	76.76M	shares	2 Qtrs
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	79.08M	shares	2 Qtrs

Cash Flow Statement 65 line items

Line Item	Tag	Value	Unit	Period
Net income (loss)	`NetIncomeLoss`	$568.00K	USD	2 Qtrs
Net income (loss)	`NetIncomeLoss`	$-43.00K	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$413.00K	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$-697.00K	USD	2 Qtrs
Depreciation	`Depreciation`	$7.91M	USD	2 Qtrs
Depreciation	`Depreciation`	$7.33M	USD	2 Qtrs
Amortization of intangibles	`AmortizationOfIntangibleAssets`	$1.60M	USD	1 Quarter
Amortization of intangibles	`AmortizationOfIntangibleAssets`	$3.64M	USD	2 Qtrs
Amortization of intangibles	`AmortizationOfIntangibleAssets`	$1.70M	USD	1 Quarter
Amortization of intangibles	`AmortizationOfIntangibleAssets`	$3.45M	USD	2 Qtrs
Amortization of debt issue costs	`AmortizationOfFinancingCosts`	$358.00K	USD	2 Qtrs
Amortization of debt issue costs	`AmortizationOfFinancingCosts`	$219.00K	USD	2 Qtrs
Stock based compensation options, restricted stock and warrants	`ShareBasedCompensationAndWarrants`	$2.34M	USD	2 Qtrs
Stock based compensation options, restricted stock and warrants	`ShareBasedCompensationAndWarrants`	$3.05M	USD	2 Qtrs
Provision for bad debts	`ProvisionForDoubtfulAccounts`	$8.03M	USD	2 Qtrs
Provision for bad debts	`ProvisionForDoubtfulAccounts`	$5.43M	USD	2 Qtrs
(Increase) in accounts receivable, net of write-offs	`IncreaseDecreaseInAccountsReceivable`	$10.00M	USD	2 Qtrs
(Increase) in accounts receivable, net of write-offs	`IncreaseDecreaseInAccountsReceivable`	$14.27M	USD	2 Qtrs
(Increase) decrease in inventories	`IncreaseDecreaseInInventories`	$-796.00K	USD	2 Qtrs
(Increase) decrease in inventories	`IncreaseDecreaseInInventories`	$437.00K	USD	2 Qtrs
(Increase) in prepaid expenses	`IncreaseDecreaseInPrepaidExpense`	$602.00K	USD	2 Qtrs
(Increase) in prepaid expenses	`IncreaseDecreaseInPrepaidExpense`	$720.00K	USD	2 Qtrs
(Increase) in other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$129.00K	USD	2 Qtrs
Increase (decrease) in accounts payable and other liabilities	`IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities`	$3.48M	USD	2 Qtrs
Increase (decrease) in accounts payable and other liabilities	`IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities`	$-2.80M	USD	2 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$4.84M	USD	2 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$12.10M	USD	2 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$3.42M	USD	2 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$7.86M	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$-3.42M	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$-7.86M	USD	2 Qtrs
Advances from revolving credit facility, net	`ProceedsFromLinesOfCredit`	$5.00M	USD	2 Qtrs
Repayment to revolving credit facility	`RepaymentsOfLinesOfCredit`	$10.04M	USD	2 Qtrs
Repayment of capital lease obligations/loans	`RepaymentsOfLongTermDebtAndCapitalSecurities`	$2.75M	USD	2 Qtrs
Repayment of capital lease obligations/loans	`RepaymentsOfLongTermDebtAndCapitalSecurities`	$2.61M	USD	2 Qtrs
Repayment on term loan, net	`RepaymentsOfLongTermLinesOfCredit`	$1.88M	USD	2 Qtrs
Proceeds from the exercise of options, warrants and ESPP shares, net of transaction expenses	`ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions`	$2.35M	USD	2 Qtrs
Proceeds from the exercise of options, warrants and ESPP shares, net of transaction expenses	`ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions`	$1.18M	USD	2 Qtrs
Payments of equity issue costs	`PaymentsOfStockIssuanceCosts`	$112.00K	USD	2 Qtrs
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$-10.30M	USD	2 Qtrs
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$1.43M	USD	2 Qtrs
Net change in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-1.63M	USD	2 Qtrs
Net change in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-1.59M	USD	2 Qtrs
Cash and cash equivalent, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$23.42M	USD	Point-in-time
Cash and cash equivalent, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$12.53M	USD	Point-in-time
Cash and cash equivalent, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$10.93M	USD	Point-in-time
Cash and cash equivalent, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$21.79M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$23.42M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$12.53M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$10.93M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$21.79M	USD	Point-in-time
Interest paid	`InterestPaid`	$2.69M	USD	2 Qtrs
Interest paid	`InterestPaid`	$2.57M	USD	2 Qtrs
Income taxes paid	`IncomeTaxesPaid`	$102.00K	USD	2 Qtrs
Income taxes paid	`IncomeTaxesPaid`	$222.00K	USD	2 Qtrs
Equipment acquired under capital lease/loan obligations	`CapitalLeaseObligationsIncurred`	$2.56M	USD	2 Qtrs
Equipment acquired under capital lease/loan obligations	`CapitalLeaseObligationsIncurred`	$2.58M	USD	2 Qtrs
Deemed dividends on preferred stock	`RedeemablePreferredStockDividends`	$929.00K	USD	1 Quarter
Deemed dividends on preferred stock	`RedeemablePreferredStockDividends`	$1.84M	USD	1 Quarter
Deemed dividends on preferred stock	`RedeemablePreferredStockDividends`	$3.68M	USD	2 Qtrs
Deemed dividends on preferred stock	`RedeemablePreferredStockDividends`	$1.82M	USD	2 Qtrs
Amortization of preferred stock beneficial conversion feature	`AmortizationOfPreferredStockBeneficialConversionFeature`	$1.71M	USD	1 Quarter
Amortization of preferred stock beneficial conversion feature	`AmortizationOfPreferredStockBeneficialConversionFeature`	$3.38M	USD	2 Qtrs
Amortization of preferred stock beneficial conversion feature	`AmortizationOfPreferredStockBeneficialConversionFeature`	$3.73M	USD	1 Quarter
Amortization of preferred stock beneficial conversion feature	`AmortizationOfPreferredStockBeneficialConversionFeature`	$7.45M	USD	2 Qtrs

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.